Gordon Johnson
Gordon Johnson is a Wall Street investor and analyst known for his anti-Tesla stance. He has been called the biggest bear on Tesla by Bloomberg and CNBC, and had the lowest price target on the street for the electric car manufacturer. Gordon is the Founder and CEO of GLJ Research, a differentiated research boutique committed to identifying unique investment opportunities across a variety of sectors. He has over 10 years of experience as an equity research analyst and was recently ranked by Bloomberg among the top stock pickers in the steel, iron ore, graphite electrode, electric vehicle, and solar spaces since initiating coverage in 2008. He has also been recognized for his accurate stock picks in numerous publications including Bloomberg, Barron’s, Forbes, The Wall Street Journal, Reuters, The Financial Times, and TheStreet.com. Prior to focusing on the solar sector, he covered semiconductor technology and solar companies at Lehman Brothers.
Gordon Johnson Professional Experience / Academic History
Professional Experience
-
Vice President
-
Sr. Equity Research Associate
-
Equity Research Associate
-
Investment Banking Analyst
Academic History
-
B.A., Finance & Economics
GLJ RESEARCH GLJ targets relatively unresearched businesses in its quest to help investors add alpha. GLJ covers 14 stocks in the solar, bulk commodity, rail, electric car, Li-Ion, and Cannabis sectors. GLJ intends on developing home-grown/talented analysts focused on providing truly unique/value-added analysis to our institutional clients. EARLY CAREER Prior to launching GLJ Research, he was a Managing Director at Vertical Group, a privately-held investment bank. He was a Managing Director at Axiom Capital, where he initiated coverage on 11 solar energy-related stocks, ranging from small to large cap. During his time at Axiom, he was recognized as a leading analyst and thought leader in alternative energy. He was VP at Lehman Brothers where he created and maintained extensive financial models and financial statements forecasting. He was Sr. Equity Research Associate at Bear Stearns's Healthcare Distribution & IT Team where he won a proprietary Research award. He was an Equity Research Associate at Credit Suisse, where he initiated coverage on 6 large-cap medical device companies. He was an Investment Banking Analyst at JP Morgan, where he advised financial institutions using trust preferred and equity-linked securities. MEDIA & APPEARANCES